GSK strikes deal with US to lower prescription drug costs & boost respiratory medicine access
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
Miels will formally assume the role on January 1, 2026
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Company to open new headquarters in 2024
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Subscribe To Our Newsletter & Stay Updated